Skip to content

Effect of an Optimal Heart Team Protocol on Decision-making Stability

The Effect of an Optimal Heart Team Implementation Protocol on the Stability of Decision-making for Complex Coronary Artery Disease-a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05039567
Enrollment
84
Registered
2021-09-09
Start date
2022-01-04
Completion date
2023-02-28
Last updated
2023-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Heart Team protocol, Coronary Artery Disease, decision-making agreement

Brief summary

This study is aimed to evaluate the effect of the optimal heart team implementation protocol on the stability of decision-making for patients with complex coronary artery disease.

Detailed description

Current guidelines recommend a heart team in the decision making for patients with complex coronary artery disease (CAD). Previous study reported that the agreement between heart teams for revascularization decision-making in complex CAD patients was moderate. Potential factors associated with decision discrepancies were summarized in several aspects and a detailed heart team implementation protocol was generated and further validation is needed. This study is designed to evaluate the effect of the optimal heart team implementation protocol on the stability of decision-making for patients with complex coronary artery disease.

Interventions

BEHAVIORALoptimal heart team protocol

Heart teams in the experimental group will be established and trained based on the optimal heart team implementation protocol. The protocol included instructions on specialist selection, specialist training, team composition, team training and formal implementation precess.

Sponsors

China National Center for Cardiovascular Diseases
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

Eligibility Criteria for patients: Inclusion Criteria: Patients with stable CAD according to the National Cardiovascular Data Registry (NCDR) CathPCI criteria (stable angina, no or silent myocardial ischemia) and angiographically confirmed 3-vessel disease or left main disease.

Exclusion criteria

1. prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG); 2. cardiac troponin I (CTnI) greater than the local laboratory upper limit of normal or recent myocardial infarction with CTnI levels still elevated; 3. concomitant severe valvular disease, macrovascular disease, or huge ventricular aneurysm requiring surgery; 4. concomitant atrial fibrillation or severe arrhythmia Eligibility Criteria for specialists: Inclusion Criteria for interventional cardiologists: 1. Annual PCI volume ≥200 2. Annual left main PCI volume ≥25 3. Capable of chronic total occlusion(CTO) PCI 4. Clinical researcher experience in coronary revascularization 5. Proficient in clinical guidelines Inclusion Criteria for cardiac surgeons: 1. CABG total volume ≥200 2. Proficient in both on-pump and off-pump CABG 3. Clinical researcher experience in coronary revascularization 4. Proficient in clinical guidelines Inclusion Criteria for non-interventional cardiologists: 1\) Proficient in clinical guidelines

Design outcomes

Primary

MeasureTime frameDescription
Overall percent agreementthrough study completion, an average of 1 yearThe proportion of patients who received unanimous decision recommendations from the heart team

Secondary

MeasureTime frameDescription
Kappa value of heart team decision-makingthrough study completion, an average of 1 yearFliess's (more than 2 raters) and Cohen's (2 raters) kappa coefficients to evaluate inter-team, inter-specialist, and inter-round agreement for treatment decisions.
Inappropriate decision ratethrough study completion, an average of 1 yearAccording to the American College of Cardiology/American Association for Thoracic Surgery/American Heart Association 2017 Appropriate Use Criteria for coronary revascularization, the inappropriate decision rate od decision-making
Compliance rate in real-world treatmentthrough study completion, an average of 1 yearCompliance is defined as the patient's actual treatment meeting the recommendations of either heart team
Reproducibility of decision-makingAt 1-month after first phase of heart team meetingAll cases will be discussed by the same heart team to evaluate the intra-team consistency in decision-making.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026